
Opinion|Videos|September 23, 2024
Considerations for Dose Modifications
The discussion addresses when dose modifications are typically required in chronic lymphocytic leukemia treatment and identifies the most common reasons for these modifications.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- When do patients typically require dose modification in chronic lymphocytic leukemia (CLL) treatment, and what are the most common reasons for dose modifications in CLL treatments?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Subcutaneous Isatuximab Could Compete With Daratumumab in Multiple Myeloma
2
FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening
3
Beyond Off-Label: How Auvelity's Approval Changes Agitation Management in Alzheimer Disease
4
What Does the FDA Advisory Committee’s Vote on 7 Peptides Mean for Pharmacy Practice?
5







































































































